<scp>MarkVCID2</scp> Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics

MarkVCID2 baseline data indicate successful enrollment of diverse individuals enriched in factors associated with SVD-related cognitive decline. Changes over 3 years of longitudinal follow-up will be analyzed to validate the candidate biomarkers for 2 projected contexts of use: subject selection (identifying likelihood of future SVD progression) and study outcome (efficiently measuring SVD progression). ANN NEUROL 2026;99:449-458.

Authors

Institutions

Publication Details

Journal
Annals of Neurology
Published
2025-09-22
DOI
https://doi.org/10.1002/ana.78040
Citations
3
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
4.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics

Bruce M. Psaty, Christian Lachner, Deborah Blacker, Gregory A. Jicha et al.
3 citations
Annals of Neurology
Dementia and Cognitive Impairment Research
4.41
article

MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics

Bruce M. Psaty, Christian Lachner, Deborah Blacker, Gregory A. Jicha, Hillary Mulder, Donna M. Wilcock, Andria L. Ford, Sudha S. Seshadri, Jin‐Moo Lee, Hanzhang Lu, Joel H. Kramer, Julie A. Schneider, Peiying Liu, Arvind Caprihan, Sue Moy, Sean I. Savitz, Lisa Wruck, Lidiya Mazina, Prashanthi Vemuri, Ronald Carl Petersen, Hongyu An, Konstantinos Arfanakis, Pauline Maillard, Arnold M Evia, B. Gwen Windham, Gary A. Rosenberg, Courtney Page, Carissa Tuozzo, Kristin Schwab, Gregory Scott Day, Steven Mark Greenberg, Roderick A. Corriveau, Danny J.J. Wang, Jason D. Hinman, Herpreet Singh, Pia Kivisäkk, Amir H. Kashani, John M. Ringman, Marylin S. Albert, Karl G. Helmer, Rong Zhang, Myriam Fornage, Claudia Liliana Satizábal, Vilma Okey‐Ewurum
article en
3 citations

Abstract

MarkVCID2 baseline data indicate successful enrollment of diverse individuals enriched in factors associated with SVD-related cognitive decline. Changes over 3 years of longitudinal follow-up will be analyzed to validate the candidate biomarkers for 2 projected contexts of use: subject selection (identifying likelihood of future SVD progression) and study outcome (efficiently measuring SVD progression). ANN NEUROL 2026;99:449-458.

Annals of NeurologyVol. 99(2)
University of Southern California (US), University of Maryland, Baltimore (US), Rush University Medical Center (US), Kennedy Krieger Institute (US), Mind Research Network (US), Harvard University (US), University of Kentucky (US), Johns Hopkins University (US), University of California, Los Angeles (US), The University of Texas at San Antonio Health Science Center (US), University of New Mexico (US), Duke University (US), University of California, San Francisco (US), Illinois Institute of Technology (US), Neurosciences Institute (US), Washington University in St. Louis (US), Johns Hopkins Medicine (US), Jacksonville College (US), WinnMed (US), University of Mississippi Medical Center (US), Massachusetts General Hospital (US), Clinical Research Institute (US), Southwestern Medical Center (US), Mallinckrodt (United States) (US), National Institute of Neurological Disorders and Stroke (US), Baim Institute for Clinical Research (US), Institute for Neurodegenerative Disorders (US), Department of Health (TW), Mayo Clinic in Arizona (US), Brown Foundation (US), Mayo Clinic in Florida (US), The University of Texas Health Science Center (US), Southwestern Medical Center (US), Indiana University – Purdue University Indianapolis (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), The University of Texas Health Science Center at Houston (US)
Openalex Percentile: Top 5%
Dementia and Cognitive Impairment Research
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.